Compugen (CGEN) Cash from Investing Activities (2009 - 2010)
Compugen (CGEN) posted quarterly Cash from Investing Activities of $3.0 million for Q4 2010, up 651.12% year-over-year from $394746.3 in Q4 2009, and up 140.55% on a QoQ basis from -$7.3 million in Q3 2010.
Powered by 
Analysis
Compugen (CGEN) Cash from Investing Activities (2009 - 2010) Analysis & Trends
Compugen has reported Cash from Investing Activities for 2 years, with the latest figure at $3.0 million in Q4 2010.
- Cash from Investing Activities for Q4 2010 came in at $3.0 million, up 651.12% year-over-year; the trailing twelve-month figure through Dec 2010 was -$4.9 million (changed N/A YoY), and the FY2025 annual result was $30.0 million, up 164.85% from the prior year.
- Cash from Investing Activities climbed to $3.0 million in Q4 2010, from -$7.3 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at $3.0 million in Q4 2010 and troughed at -$7.3 million in Q3 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 329.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -1.66 Bn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | -49.35 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -363.46 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -229.72 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 24.51 Mn |
| 10 | Compugen | 242.44 Mn | 156.82 Mn | -92,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2010 | 2.97 Mn |
| Sep 30, 2010 | -7.31 Mn |
| Dec 31, 2009 | -538,000.00 |
| Sep 30, 2009 | 18,000.00 |